Global Lisinopril Market Research Report 2023

Global Lisinopril Market Research Report 2023

Table of Contents
1 Lisinopril Market Overview
1.1 Product Overview and Scope of Lisinopril
1.2 Lisinopril Segment by Type
1.2.1 Global Lisinopril Market Value Comparison by Type (2023-2029)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Lisinopril Segment by Application
1.3.1 Global Lisinopril Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Revenue 2018-2029
1.4.2 Global Lisinopril Sales 2018-2029
1.4.3 Global Lisinopril Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lisinopril Market Competition by Manufacturers
2.1 Global Lisinopril Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lisinopril Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lisinopril Average Price by Manufacturers (2018-2023)
2.4 Global Lisinopril Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Lisinopril, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lisinopril, Product Type & Application
2.7 Lisinopril Market Competitive Situation and Trends
2.7.1 Lisinopril Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lisinopril Players Market Share by Revenue
2.7.3 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lisinopril Retrospective Market Scenario by Region
3.1 Global Lisinopril Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lisinopril Global Lisinopril Sales by Region: 2018-2029
3.2.1 Global Lisinopril Sales by Region: 2018-2023
3.2.2 Global Lisinopril Sales by Region: 2024-2029
3.3 Global Lisinopril Global Lisinopril Revenue by Region: 2018-2029
3.3.1 Global Lisinopril Revenue by Region: 2018-2023
3.3.2 Global Lisinopril Revenue by Region: 2024-2029
3.4 North America Lisinopril Market Facts & Figures by Country
3.4.1 North America Lisinopril Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lisinopril Sales by Country (2018-2029)
3.4.3 North America Lisinopril Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lisinopril Market Facts & Figures by Country
3.5.1 Europe Lisinopril Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lisinopril Sales by Country (2018-2029)
3.5.3 Europe Lisinopril Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lisinopril Market Facts & Figures by Country
3.6.1 Asia Pacific Lisinopril Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lisinopril Sales by Country (2018-2029)
3.6.3 Asia Pacific Lisinopril Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lisinopril Market Facts & Figures by Country
3.7.1 Latin America Lisinopril Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lisinopril Sales by Country (2018-2029)
3.7.3 Latin America Lisinopril Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lisinopril Market Facts & Figures by Country
3.8.1 Middle East and Africa Lisinopril Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lisinopril Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lisinopril Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lisinopril Sales by Type (2018-2029)
4.1.1 Global Lisinopril Sales by Type (2018-2023)
4.1.2 Global Lisinopril Sales by Type (2024-2029)
4.1.3 Global Lisinopril Sales Market Share by Type (2018-2029)
4.2 Global Lisinopril Revenue by Type (2018-2029)
4.2.1 Global Lisinopril Revenue by Type (2018-2023)
4.2.2 Global Lisinopril Revenue by Type (2024-2029)
4.2.3 Global Lisinopril Revenue Market Share by Type (2018-2029)
4.3 Global Lisinopril Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lisinopril Sales by Application (2018-2029)
5.1.1 Global Lisinopril Sales by Application (2018-2023)
5.1.2 Global Lisinopril Sales by Application (2024-2029)
5.1.3 Global Lisinopril Sales Market Share by Application (2018-2029)
5.2 Global Lisinopril Revenue by Application (2018-2029)
5.2.1 Global Lisinopril Revenue by Application (2018-2023)
5.2.2 Global Lisinopril Revenue by Application (2024-2029)
5.2.3 Global Lisinopril Revenue Market Share by Application (2018-2029)
5.3 Global Lisinopril Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Actavis Elizabeth
6.1.1 Actavis Elizabeth Corporation Information
6.1.2 Actavis Elizabeth Description and Business Overview
6.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Actavis Elizabeth Lisinopril Product Portfolio
6.1.5 Actavis Elizabeth Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Apotex Lisinopril Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aurobindo Pharma Lisinopril Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Ivax Pharmaceuticals
6.4.1 Ivax Pharmaceuticals Corporation Information
6.4.2 Ivax Pharmaceuticals Description and Business Overview
6.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
6.4.5 Ivax Pharmaceuticals Recent Developments/Updates
6.5 Lek Pharmaceuticals
6.5.1 Lek Pharmaceuticals Corporation Information
6.5.2 Lek Pharmaceuticals Description and Business Overview
6.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lek Pharmaceuticals Lisinopril Product Portfolio
6.5.5 Lek Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lupin Lisinopril Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Ranbaxy Pharmaceuticals
6.8.1 Ranbaxy Pharmaceuticals Corporation Information
6.8.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
6.8.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novartis Lisinopril Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Corporation Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceuticals Lisinopril Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Vintage Pharmaceuticals
6.11.1 Vintage Pharmaceuticals Corporation Information
6.11.2 Vintage Pharmaceuticals Lisinopril Description and Business Overview
6.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
6.11.5 Vintage Pharmaceuticals Recent Developments/Updates
6.12 Watson Laboratories
6.12.1 Watson Laboratories Corporation Information
6.12.2 Watson Laboratories Lisinopril Description and Business Overview
6.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Watson Laboratories Lisinopril Product Portfolio
6.12.5 Watson Laboratories Recent Developments/Updates
6.13 West Ward Pharmaceutical
6.13.1 West Ward Pharmaceutical Corporation Information
6.13.2 West Ward Pharmaceutical Lisinopril Description and Business Overview
6.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.13.4 West Ward Pharmaceutical Lisinopril Product Portfolio
6.13.5 West Ward Pharmaceutical Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Lisinopril Description and Business Overview
6.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Wockhardt Lisinopril Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Merck Research Laboratories
6.15.1 Merck Research Laboratories Corporation Information
6.15.2 Merck Research Laboratories Lisinopril Description and Business Overview
6.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Merck Research Laboratories Lisinopril Product Portfolio
6.15.5 Merck Research Laboratories Recent Developments/Updates
6.16 Astrazeneca
6.16.1 Astrazeneca Corporation Information
6.16.2 Astrazeneca Lisinopril Description and Business Overview
6.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Astrazeneca Lisinopril Product Portfolio
6.16.5 Astrazeneca Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Corporation Information
6.17.2 Alvogen Lisinopril Description and Business Overview
6.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Alvogen Lisinopril Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Hikma
6.18.1 Hikma Corporation Information
6.18.2 Hikma Lisinopril Description and Business Overview
6.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Hikma Lisinopril Product Portfolio
6.18.5 Hikma Recent Developments/Updates
6.19 Prinston
6.19.1 Prinston Corporation Information
6.19.2 Prinston Lisinopril Description and Business Overview
6.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Prinston Lisinopril Product Portfolio
6.19.5 Prinston Recent Developments/Updates
6.20 Accord Hlthcare
6.20.1 Accord Hlthcare Corporation Information
6.20.2 Accord Hlthcare Lisinopril Description and Business Overview
6.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Accord Hlthcare Lisinopril Product Portfolio
6.20.5 Accord Hlthcare Recent Developments/Updates
6.21 CASI Pharms
6.21.1 CASI Pharms Corporation Information
6.21.2 CASI Pharms Lisinopril Description and Business Overview
6.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.21.4 CASI Pharms Lisinopril Product Portfolio
6.21.5 CASI Pharms Recent Developments/Updates
6.22 Invagen Pharms
6.22.1 Invagen Pharms Corporation Information
6.22.2 Invagen Pharms Lisinopril Description and Business Overview
6.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Invagen Pharms Lisinopril Product Portfolio
6.22.5 Invagen Pharms Recent Developments/Updates
6.23 SUN Pharm
6.23.1 SUN Pharm Corporation Information
6.23.2 SUN Pharm Lisinopril Description and Business Overview
6.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2018-2023)
6.23.4 SUN Pharm Lisinopril Product Portfolio
6.23.5 SUN Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lisinopril Industry Chain Analysis
7.2 Lisinopril Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lisinopril Production Mode & Process
7.4 Lisinopril Sales and Marketing
7.4.1 Lisinopril Sales Channels
7.4.2 Lisinopril Distributors
7.5 Lisinopril Customers
8 Lisinopril Market Dynamics
8.1 Lisinopril Industry Trends
8.2 Lisinopril Market Drivers
8.3 Lisinopril Market Challenges
8.4 Lisinopril Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Lisinopril Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Lisinopril Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Lisinopril Market Competitive Situation by Manufacturers in 2022
Table 4. Global Lisinopril Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Lisinopril Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Lisinopril Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Lisinopril Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Lisinopril Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Lisinopril, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Lisinopril, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lisinopril, Product Type & Application
Table 12. Global Key Manufacturers of Lisinopril, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lisinopril by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lisinopril Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Lisinopril Sales by Region (2018-2023) & (K Units)
Table 18. Global Lisinopril Sales Market Share by Region (2018-2023)
Table 19. Global Lisinopril Sales by Region (2024-2029) & (K Units)
Table 20. Global Lisinopril Sales Market Share by Region (2024-2029)
Table 21. Global Lisinopril Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Lisinopril Revenue Market Share by Region (2018-2023)
Table 23. Global Lisinopril Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Lisinopril Revenue Market Share by Region (2024-2029)
Table 25. North America Lisinopril Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Lisinopril Sales by Country (2018-2023) & (K Units)
Table 27. North America Lisinopril Sales by Country (2024-2029) & (K Units)
Table 28. North America Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Lisinopril Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Lisinopril Sales by Country (2018-2023) & (K Units)
Table 32. Europe Lisinopril Sales by Country (2024-2029) & (K Units)
Table 33. Europe Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Lisinopril Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Lisinopril Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Lisinopril Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Lisinopril Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Lisinopril Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Lisinopril Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Lisinopril Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Lisinopril Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Lisinopril Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Lisinopril Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Lisinopril Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Lisinopril Sales (K Units) by Type (2018-2023)
Table 51. Global Lisinopril Sales (K Units) by Type (2024-2029)
Table 52. Global Lisinopril Sales Market Share by Type (2018-2023)
Table 53. Global Lisinopril Sales Market Share by Type (2024-2029)
Table 54. Global Lisinopril Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Lisinopril Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Lisinopril Revenue Market Share by Type (2018-2023)
Table 57. Global Lisinopril Revenue Market Share by Type (2024-2029)
Table 58. Global Lisinopril Price (US$/Unit) by Type (2018-2023)
Table 59. Global Lisinopril Price (US$/Unit) by Type (2024-2029)
Table 60. Global Lisinopril Sales (K Units) by Application (2018-2023)
Table 61. Global Lisinopril Sales (K Units) by Application (2024-2029)
Table 62. Global Lisinopril Sales Market Share by Application (2018-2023)
Table 63. Global Lisinopril Sales Market Share by Application (2024-2029)
Table 64. Global Lisinopril Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Lisinopril Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Lisinopril Revenue Market Share by Application (2018-2023)
Table 67. Global Lisinopril Revenue Market Share by Application (2024-2029)
Table 68. Global Lisinopril Price (US$/Unit) by Application (2018-2023)
Table 69. Global Lisinopril Price (US$/Unit) by Application (2024-2029)
Table 70. Actavis Elizabeth Corporation Information
Table 71. Actavis Elizabeth Description and Business Overview
Table 72. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Actavis Elizabeth Lisinopril Product
Table 74. Actavis Elizabeth Recent Developments/Updates
Table 75. Apotex Corporation Information
Table 76. Apotex Description and Business Overview
Table 77. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Apotex Lisinopril Product
Table 79. Apotex Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Aurobindo Pharma Lisinopril Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Ivax Pharmaceuticals Corporation Information
Table 86. Ivax Pharmaceuticals Description and Business Overview
Table 87. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Ivax Pharmaceuticals Lisinopril Product
Table 89. Ivax Pharmaceuticals Recent Developments/Updates
Table 90. Lek Pharmaceuticals Corporation Information
Table 91. Lek Pharmaceuticals Description and Business Overview
Table 92. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Lek Pharmaceuticals Lisinopril Product
Table 94. Lek Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Corporation Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Lupin Lisinopril Product
Table 99. Lupin Recent Developments/Updates
Table 100. Mylan Pharmaceuticals Corporation Information
Table 101. Mylan Pharmaceuticals Description and Business Overview
Table 102. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Mylan Pharmaceuticals Lisinopril Product
Table 104. Mylan Pharmaceuticals Recent Developments/Updates
Table 105. Ranbaxy Pharmaceuticals Corporation Information
Table 106. Ranbaxy Pharmaceuticals Description and Business Overview
Table 107. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Ranbaxy Pharmaceuticals Lisinopril Product
Table 109. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Novartis Lisinopril Product
Table 114. Novartis Recent Developments/Updates
Table 115. Teva Pharmaceuticals Corporation Information
Table 116. Teva Pharmaceuticals Description and Business Overview
Table 117. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Teva Pharmaceuticals Lisinopril Product
Table 119. Teva Pharmaceuticals Recent Developments/Updates
Table 120. Vintage Pharmaceuticals Corporation Information
Table 121. Vintage Pharmaceuticals Description and Business Overview
Table 122. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Vintage Pharmaceuticals Lisinopril Product
Table 124. Vintage Pharmaceuticals Recent Developments/Updates
Table 125. Watson Laboratories Corporation Information
Table 126. Watson Laboratories Description and Business Overview
Table 127. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Watson Laboratories Lisinopril Product
Table 129. Watson Laboratories Recent Developments/Updates
Table 130. West Ward Pharmaceutical Corporation Information
Table 131. West Ward Pharmaceutical Description and Business Overview
Table 132. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. West Ward Pharmaceutical Lisinopril Product
Table 134. West Ward Pharmaceutical Recent Developments/Updates
Table 135. Wockhardt Corporation Information
Table 136. Wockhardt Description and Business Overview
Table 137. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Wockhardt Lisinopril Product
Table 139. Wockhardt Recent Developments/Updates
Table 140. Merck Research Laboratories Corporation Information
Table 141. Merck Research Laboratories Description and Business Overview
Table 142. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Merck Research Laboratories Lisinopril Product
Table 144. Merck Research Laboratories Recent Developments/Updates
Table 145. Astrazeneca Corporation Information
Table 146. Astrazeneca Description and Business Overview
Table 147. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Astrazeneca Lisinopril Product
Table 149. Astrazeneca Recent Developments/Updates
Table 150. Alvogen Corporation Information
Table 151. Alvogen Description and Business Overview
Table 152. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Alvogen Lisinopril Product
Table 154. Alvogen Recent Developments/Updates
Table 155. Hikma Corporation Information
Table 156. Hikma Description and Business Overview
Table 157. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Hikma Lisinopril Product
Table 159. Hikma Recent Developments/Updates
Table 160. Prinston Corporation Information
Table 161. Prinston Description and Business Overview
Table 162. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Prinston Lisinopril Product
Table 164. Prinston Recent Developments/Updates
Table 165. Accord Hlthcare Corporation Information
Table 166. Accord Hlthcare Description and Business Overview
Table 167. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Accord Hlthcare Lisinopril Product
Table 169. Accord Hlthcare Recent Developments/Updates
Table 170. CASI Pharms Corporation Information
Table 171. CASI Pharms Description and Business Overview
Table 172. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. CASI Pharms Lisinopril Product
Table 174. CASI Pharms Recent Developments/Updates
Table 175. Invagen Pharms Corporation Information
Table 176. Invagen Pharms Description and Business Overview
Table 177. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Invagen Pharms Lisinopril Product
Table 179. Invagen Pharms Recent Developments/Updates
Table 180. SUN Pharm Corporation Information
Table 181. SUN Pharm Description and Business Overview
Table 182. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 183. SUN Pharm Lisinopril Product
Table 184. SUN Pharm Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Lisinopril Distributors List
Table 188. Lisinopril Customers List
Table 189. Lisinopril Market Trends
Table 190. Lisinopril Market Drivers
Table 191. Lisinopril Market Challenges
Table 192. Lisinopril Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lisinopril
Figure 2. Global Lisinopril Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Lisinopril Market Share by Type in 2022 & 2029
Figure 4. 2.5mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. 10mg Product Picture
Figure 7. 20mg Product Picture
Figure 8. 30mg Product Picture
Figure 9. 40mg Product Picture
Figure 10. Global Lisinopril Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Lisinopril Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Drug Store
Figure 14. Global Lisinopril Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Lisinopril Market Size (2018-2029) & (US$ Million)
Figure 16. Global Lisinopril Sales (2018-2029) & (K Units)
Figure 17. Global Lisinopril Average Price (US$/Unit) & (2018-2029)
Figure 18. Lisinopril Report Years Considered
Figure 19. Lisinopril Sales Share by Manufacturers in 2022
Figure 20. Global Lisinopril Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Lisinopril Players: Market Share by Revenue in 2022
Figure 22. Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Lisinopril Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Lisinopril Sales Market Share by Country (2018-2029)
Figure 25. North America Lisinopril Revenue Market Share by Country (2018-2029)
Figure 26. United States Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Lisinopril Sales Market Share by Country (2018-2029)
Figure 29. Europe Lisinopril Revenue Market Share by Country (2018-2029)
Figure 30. Germany Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Lisinopril Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Lisinopril Revenue Market Share by Region (2018-2029)
Figure 37. China Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Lisinopril Sales Market Share by Country (2018-2029)
Figure 47. Latin America Lisinopril Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Lisinopril Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Lisinopril Sales Market Share by Country (2018-2029)
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs